Orchard Therapeutics Announces Multiple Presentations at
Three oral presentations and seven posters highlight transformative potential of HSC gene therapy and newborn screening to address severe neurometabolic...
Source: globenewswire.com
Page 35 - Priority Review News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Priority Review Today - Breaking & Trending Today
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
Results Reflect Continued Strength of In-Line and New Products, Pipeline Execution and Business Development Activity, Supporting Growth Momentum into 2024 Reports Fourth Quarter Revenues of...
Source: marketscreener.com
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
Validation is supported by data from Phase 3 innovaTV 301 trial ...
Source: marketscreener.com
Trastuzumab Deruxtecan Gets Priority Review for Metastatic HER2+ Solid Tumors
Enhertu is under Priority Review for the treatment of previously treated adults with unresectable or metastatic HER2+ IHC 3+ solid tumors.
Source: oncologynurseadvisor.com
Afami-cel, a T-Cell Therapy for Advanced Synovial Sarcoma, Gets Priority Review
Afami-cel is an autologous T-cell therapy designed to target cancer cells in solid tumors expressing melanoma-associated antigen A4.
Source: empr.com